InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction-June 2024-www.financetom.com

InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

InMode Says FDA Clears Morpheus8 Technology for Soft Tissue Contraction

Jul 17, 2024 6:22 AM

08:58 AM EDT, 07/17/2024 (MT Newswires) -- InMode ( INMD ) said Wednesday it has received an additional US Food and Drug Administration's clearance for Morpheus8, a fractional radiofrequency microneedling technology for soft tissue contraction.

The regulator cleared the Morpheus8 applicators for fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is required, the medical technologies firm added.

InMode ( INMD ) has rolled out IgniteRF and OptimasMAX platforms, which include the Morpheus8 family of handpieces, it said.

Price: 18.75, Change: -0.31, Percent Change: -1.63

Previous page： GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK Next page： Navitas Semiconductor Insider Sold Shares Worth $3,057,450, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK

Sep 17, 2025

(Reuters) - Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure over five years, after U.S. President Donald Trump arrived in Britain for a second state visit to seal investment deals. The company said its new facilities in the U.S., which made up half its revenue last year, would bridge R&D...

Navitas Semiconductor Insider Sold Shares Worth $3,057,450, According to a Recent SEC Filing

Sep 17, 2025

03:45 AM EDT, 09/17/2025 (MT Newswires) -- Brian Long, Director, on September 15, 2025, sold 500,000 shares in Navitas Semiconductor ( NVTS ) for $3,057,450. Following the Form 4 filing with the SEC, Long has control over a total of 1,737,443 Class A common shares of the company, with 22,048 shares held directly and 1,715,395 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1821769/000120101025000025/xslF345X05/wk-form4_1758067892.xml...

STMicroelectronics to Launch New Microchip Packaging Technology at France Site

Sep 17, 2025

04:05 AM EDT, 09/17/2025 (MT Newswires) -- STMicroelectronics ( STM ) said Wednesday that its panel-level packaging technology is expected to begin operations at its site in Tours, France, in Q3 2026. The company said the automated chip-packaging and test process technology increases manufacturing efficiency and reduces costs, as well as enabling the creation of smaller, more powerful, and cost-effective...

Peloton Interactive Insider Sold Shares Worth $1,184,150, According to a Recent SEC Filing

Sep 17, 2025

03:42 AM EDT, 09/17/2025 (MT Newswires) -- Peter C Stern, Director, President and Chief Executive Officer, on September 15, 2025, sold 152,265 shares in Peloton Interactive ( PTON ) for $1,184,150. Following the Form 4 filing with the SEC, Stern has control over a total of 130,221 Class A common shares of the company, with 130,221 shares held directly. SEC...